NOTIFICATION OF TRADE AMONG PRIMARY INSIDERS

On September 18 2008 mandatory notifications of trade among primary insiders of DiaGenic ASA took place. The primary insiders entered into a 6 month forward contract for the purchase of 410,000 shares at NOK 6.2356 per share. This contract is a continuation of the forward contract entered into on September 18 2007 for the same number of shares. The transactions made no changes in the net exposure among the insiders. The transactions are described in more detail below.

Today, CEO Erik Christensen has entered into a 6 month forward contract for the purchase of 50,000 shares in DiaGenic at NOK 6.2356 per share. This contract is a continuation of the forward contract entered into September 18, 2007 for the same number of shares. Christensen`s exposure in the Company is unchanged at a total of 130,000 shares.

Håkon Sæterøy, Chairman of the Board of DiaGenic ASA, has entered into a 6 month forward contract for purchase of 100,000 shares at NOK 6.2356 per share. This contract is a continuation of the forward contract entered into September 18, 2007 for the same number of shares. Sæterøy`s overall exposure in the Company is unchanged at a total of 1,303,478 shares.

Director and board member Praveen Sharma has entered into a 6 months forward contract for purchase of 260,000 shares at NOK 6.2356 per share. This contract is a continuation of the forward contract entered into September 18, 2007 for the same number of shares. After the transaction Sharma controls a total of 3,170,000 shares in DiaGenic, unchanged by the transaction.

Contact:
MD PhD Erik Christensen, Managing Director
Telephone: +47 95939918
e-mail: erik.christensen@diagenic.com